EUVIMEDEUVIMED entdecken
Crossref

Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer

Jose G. Bazan, Christopher R. King, James D. Brooks, Sandy Srinivas

The Open Prostate Cancer Journal · 2010

DOI: 10.2174/1876822901003010099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Prostate Cancer Journal, 2010. Verfasst von Jose G. Bazan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bazan, J. G., King, C. R., Brooks, J. D., & Srinivas, S. (2010). Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer. The Open Prostate Cancer Journal. https://doi.org/10.2174/1876822901003010099

Vancouver

Bazan JG, King CR, Brooks JD, Srinivas S. Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer. The Open Prostate Cancer Journal. 2010. doi:10.2174/1876822901003010099

BibTeX
@article{Bazan2010,
  author = {Bazan, Jose G. and King, Christopher R. and Brooks, James D. and Srinivas, Sandy},
  title = {Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer},
  journal = {The Open Prostate Cancer Journal},
  year = {2010},
  doi = {10.2174/1876822901003010099}
}
Kostenlos starten →